Diphosphonate single-photon emission computed tomography in cardiac transthyretin amyloidosis.


Journal

International journal of cardiology
ISSN: 1874-1754
Titre abrégé: Int J Cardiol
Pays: Netherlands
ID NLM: 8200291

Informations de publication

Date de publication:
15 05 2020
Historique:
received: 24 11 2019
revised: 26 01 2020
accepted: 10 02 2020
pubmed: 23 2 2020
medline: 31 5 2022
entrez: 22 2 2020
Statut: ppublish

Résumé

Planar diphosphonate scintigraphy is an established diagnostic tool for amyloid transthyretin (ATTR) cardiomyopathy. Characterization of the amyloid burden up to the segmental level by single photon emission computed tomography (SPECT) has not been evaluated so far. Data from consecutive patients undergoing cardiac Thirty-eight patients were included (median age 81 years, 79% men, 92% with wild-type ATTR). In patients with Perugini score 1, the most intense diphosphonate regional uptake was found in septal segments, particularly in infero-septal segments. Among patients scoring 2, the amyloid burden in the septum became more significant, and extended to inferior and apical segments. Finally, patients scoring 3 displayed an intense and widespread tracer uptake. All patients with Perugini score 1 had LGE in at least one antero-septal, one infero-septal, and one infero-lateral segment. All patients with score 2 displayed LGE in infero-septal, inferior, and infero-lateral segments. LGE became extensive in patients scoring 3, with all patients having at least one LGE-positive segment in each region. When assimilating different Perugini grades to evolutive stages of the disease, amyloid deposition seem to progress from the septum to the inferior wall and then to the other regions and from the basis to the apex. The potential of segmental analysis might be particularly relevant in patients with very limited cardiac uptake at planar scintigraphy (Perugini score 1).

Sections du résumé

BACKGROUND
Planar diphosphonate scintigraphy is an established diagnostic tool for amyloid transthyretin (ATTR) cardiomyopathy. Characterization of the amyloid burden up to the segmental level by single photon emission computed tomography (SPECT) has not been evaluated so far.
METHODS
Data from consecutive patients undergoing cardiac
RESULTS
Thirty-eight patients were included (median age 81 years, 79% men, 92% with wild-type ATTR). In patients with Perugini score 1, the most intense diphosphonate regional uptake was found in septal segments, particularly in infero-septal segments. Among patients scoring 2, the amyloid burden in the septum became more significant, and extended to inferior and apical segments. Finally, patients scoring 3 displayed an intense and widespread tracer uptake. All patients with Perugini score 1 had LGE in at least one antero-septal, one infero-septal, and one infero-lateral segment. All patients with score 2 displayed LGE in infero-septal, inferior, and infero-lateral segments. LGE became extensive in patients scoring 3, with all patients having at least one LGE-positive segment in each region.
CONCLUSIONS
When assimilating different Perugini grades to evolutive stages of the disease, amyloid deposition seem to progress from the septum to the inferior wall and then to the other regions and from the basis to the apex. The potential of segmental analysis might be particularly relevant in patients with very limited cardiac uptake at planar scintigraphy (Perugini score 1).

Identifiants

pubmed: 32081469
pii: S0167-5273(19)35840-1
doi: 10.1016/j.ijcard.2020.02.030
pii:
doi:

Substances chimiques

Diphosphonates 0
Prealbumin 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

187-192

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Declaration of competing interest There is no conflict of interest to disclose.

Auteurs

Chrysanthos Grigoratos (C)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy. Electronic address: cgrigoratos@ftgm.it.

Alberto Aimo (A)

Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.

Claudio Rapezzi (C)

Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, Italy.

Dario Genovesi (D)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Andrea Barison (A)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.

Giovanni Donato Aquaro (GD)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Giuseppe Vergaro (G)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.

Angela Pucci (A)

Histopathology Department, University Hospital of Pisa, Italy.

Claudio Passino (C)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.

Paolo Marzullo (P)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Alessia Gimelli (A)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Michele Emdin (M)

Fondazione Toscana Gabriele Monasterio, Pisa, Italy; Institute of Life Sciences, Scuola Superiore Sant'Anna, Pisa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH